The following video is part of our "Motley Fool Conversations" series, in which Senior Technology Editor Eric Bleeker and fellow Fool Maggie Muraca discuss topics across the investing world.
One of The Motley Fool's company goals this year has been to get all of its employees investing and learning about how to secure their financial future. In this edition of the series, Eric Bleeker talks to Maggie Muraca, a marketing employee, to get more background on her decision to begin investing and why Abbott Labs
Eric Bleeker does not own shares of the companies listed above. Maggie Muraca owns shares of Abbott Labs and ExxonMobil. The Motley Fool owns shares of Johnson & Johnson and Abbott Labs. Motley Fool newsletter services have recommended buying shares of Abbott Labs and Johnson & Johnson, as well as creating a diagonal call position in Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
3 Fastest-Growing Diabetes Stocks of 2018 -- According to Wall Street
Analysts think these three diabetes stocks could soar more than 50% this year. But are they right?
3 Top Oil Stocks to Buy Right Now
Oil prices are at multiyear highs, but these three companies are set to profit whether they go higher or not. Here's why they're worth buying now.
This News Explains Why DexCom Is Dropping Today
Shares slide after news breaks that a competitor's product nabs an important reimbursement win.